Skip to main content

Shaping the Future of Neurological Therapies

We envision a world where the limitations of traditional treatments for brain tumors and neurological disorders are surpassed by the precision and effectiveness of Brain-Computer Interface technology.

By implanting BCI technology into the deep brain in the form of a micro-drug delivery device, we aim to employ convection-enhanced principles to bypass the blood brain barrier in order to treat brain tumors such as Glioblastoma Multiforme (GBM) and a variety of neurological conditions.

Glioblastoma is one of the most complex, deadly, and treatment-resistant cancers. Survival rates and mortality statistics for GBM have remained virtually unchanged for decades.

15,000

new cases each year in the U.S.

14

months average life expectancy after diagnosis

5

of patients survive more than 5 years

We’re exploring applying our technology to additional indications:

  • Traumatic/Chronic Brain Injury
  • Epilepsy
  • Obsessive-Compulsive Disorder
  • Parkinson’s Disease
  • Huntington’s Disease
  • Depression
  • Schizophrenia
  • Post-Traumatic Stress Disorder
  • Alzheimer’s Disease
  • Chronic Pain
  • Stroke
  • Amyotrophic Lateral Sclerosis (ALS)
  • Hearing and Balance Disorders